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Summary
Objectives: To evaluate osteoarthritis (OA) of the knee using positron emission tomography (PET) with 2-18F-ﬂuoro-2-deoxy-D-glucose
(18F-FDG) as a tracer.
Materials and methods: Fifteen patients with medial-type knee OA and three healthy subjects were enrolled in the study. After clinical
examination and conventional radiography, 18F-FDG PET and magnetic resonance imaging (MRI) were performed. 18F-FDG uptake was
quantiﬁed as a standardized uptake value (SUV) and the localization of 18F-FDG uptake was identiﬁed using fusion images created with
MRI scans.
Results: 18F-FDG generally accumulated in periarticular lesions and was absent in the articular cartilage. SUVs of the whole knee were
higher in OA than in controls, and those in the medial condyle were higher than in the lateral condyle in OA. Prominent 18F-FDG uptake
was found in the intercondylar notch in OA and extended along the posterior cruciate ligament (PCL) in some cases. Periosteophytic
accumulation was found in one-half of cases with deﬁnite osteophytes. Accumulation was also found in subchondral lesions and
bone marrow, which corresponded with bone edema diagnosed by MRI. No signiﬁcant correlation was found between SUV and clinical
manifestations.
Conclusions: 18F-FDG uptake was upregulated in OA and generally accumulated in periarticular lesions. Increased uptake was found in the
intercondylar notch extending along the PCL, periosteophytic lesions, and bone marrow. These results provide in vivo pathognomonic insights
into OA.
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Cartilage
Repair
SocietyIntroduction
Osteoarthritis (OA) is characterized by degradation and loss
of articular cartilage, and remodeling of underlying bone.
Currently, conventional radiography is the standard method
for diagnosis and evaluation of severity of OA. A standing
anteroposterior (AP) view is commonly used to assess
articular degradation expressed as joint space width1,2;
however, this provides only indirect assessment of the
articular cartilage, and it takes a couple of years to detect
cartilage loss with technical concerns3e5. Thus, reﬁned
imaging techniques and modalities have been studied to
detect molecular properties and metabolic changes in
cartilage4.
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lar cartilage and accurately assess cartilage volume and
thickness6,7. The cartilage volumes computed by three-
dimensional (3D) reconstruction of MRI images are compa-
rable to those evaluated by computed tomography (CT)
arthrography and those from surgically removed cartilage.
Moreover, glycosaminoglycan (GAG) can be visualized
using contrast agents. Gadolinium-diethylenetriamine penta-
acetic acid (DTPA) can penetrate into cartilage and distrib-
utes inversely with the GAG concentration. Delayed
gadolinium-enhanced MRI of cartilage has been validated
in clinical and basic scientiﬁc studies8.
Positron emission tomography (PET) demonstrates met-
abolic changes in target tissues. PET using 2-18F-ﬂuoro-2-
deoxy-D-glucose (18F-FDG) reﬂects glucose metabolism,
and can detect the foci of malignant tumors, infection
and inﬂammation9,10. 18F-FDG PET is now widely used
in oncology9; however, its application in rheumatic disease
is limited. Synovial volume evaluated by MRI was corre-
lated with the uptake of 18F-FDG in 10 cases of3
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and eight other inﬂammatory arthritis)11. Twenty-one pa-
tients with RA were evaluated by 18F-FDG PET, and the
number of PET-positive joints and the cumulative stan-
dardized uptake value (SUV) were signiﬁcantly correlated
with swollen and tender joint counts12. Case reports of
synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO)
syndrome13, psoriatic arthritis14, and RA15,16 have been
published in which 18F-FDG PET was of diagnostic value.
While conventional radiographs and MRI provide
morphological information about articular cartilage, PET
reﬂects the glucose metabolism of target organs and pro-
vides functional images. As the cartilage matrix is com-
posed of glucosaminoglycan and maintained by the
glucose metabolism of chondrocytes, changes in cartilage
metabolism might be detected by PET. Although PET is
expected to delineate the changes in OA, there have
been few reports of 18F-FDG PET in OA. The aim of
this study was to evaluate knee OA using 18F-FDG
PET images and to obtain preliminary PET features of
knee OA.
Patients and methods
PATIENTS
The inclusion criteria included medial-type knee OA
fulﬁlling ACR criteria17, with any radiological grading in
our outpatient clinic. Patients with hyperglycemia wereexcluded. Fifteen patients were recruited in the study
(13 females, two males; average age of 71.5 years). After
clinical examination (effusion, swelling, rest pain, motion
pain, and tenderness), the patients underwent AP view
radiography in the standing position to evaluate the
Kellgren/Lawrence (K/L) grade18. About 1 week later,
they were subjected to MRI and 18F-FDG PET on the
same day. Young, healthy volunteers (one female, two
males; average age of 26.3 years) were also investigated.
The study was approved by the ethical committee of the
institutes.
MRI
To identify the site of 18F-FDG accumulation, MRI was
undertaken. Before PET examination, MRI was performed
on a Gyroscan Intera 1.5 T (Philips, Netherlands) with
a microscopy coil (47 mm). Coronal images were ac-
quired with a proton density-weighted sequence (repeti-
tion time¼ 1500 ms, echo time¼ 15 ms, thickness¼
2 mm, ﬁeld of vision¼ 8 cm) and a fat-suppressed se-
quence (repetition time¼ 20 ms, echo time¼ 9.8 ms, ﬂip
angle¼ 30, thickness¼ 2 mm, ﬁeld of vision¼ 8 cm).
The patients lay supine, and the leg was set with a spe-
ciﬁc triangular pillow to obtain an identical position in the
PET examination. For fusion images, both MRI and PET
scans started at exactly 5 cm proximal to the upper end
of the patella.Fig. 1. Representative coronal (A,D) and axial (B,C,E) sections of PET images in a knee with OA (AeC) and in a control knee (D,E). 18F-FDG
uptake was emphasized by sequential colorization ranging from red (high) to blue (low) (C). 18F-FDG commonly accumulated in the periar-
ticular region and was lacking in the articular cartilage. M: medial, L: lateral.
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Fig. 2. The SUVs of whole knees were assessed using 3D data (A,B). Both peak (C) and mean (D) SUVs were signiﬁcantly higher in OA than
in controls. The data were expressed as the mean and standard deviation, and compared using Student’s t-test. *P< 0.01.18F-FDG PET
18F-FDG PET was performed using an Eminence SET-
3000G (Shimazu, Japan) operated in 3D mode. The effec-
tive ﬁeld of view was 256 mm in the x-, y-, and z-directions.
The patients fasted for at least 6 h before injection and were
at rest for 15 min after injection to reduce muscular uptake.
Before injection, blood glucose levels were measured; in all
cases, they were under 100 mg/dL. The patients were
injected with 18F-FDG (3.5 MBq/kg) in a peripheral vein,
with imaging 50 min after the injection. This optimal interval
was determined by a time-course study performed in
advance. Semiquantitative 18F-FDG uptake was expressed
as the SUV normalized for the lean body mass.
DIGITAL IMAGE PROCESSING
Digital images were processed using a high-performance
graphic system (Virtual Place; AZE, Japan). To assess
SUV, the region of interest was positioned arbitrarily on
a 3D image, values were calculated, and an SUV was
determined for each knee. SUV intensity was colored toemphasize the uptake intensity ranging from red (high) to
blue (low) as needed. Digital data were transferred to the
system and fusion images were created automatically with
some manual adjustment. To observe the localization of
18F-FDG closely, the fusion images focused on the medial
compartment.
STATISTICAL ANALYSIS
SUVs in OA and healthy controls were compared using
Student’s t-test, and the medial and lateral condyles were
compared with a paired t-test. The relationship of SUVs
with clinical manifestations and radiological grading was
analyzed by Student’s t-test and one-way analysis of vari-
ance (ANOVA), respectively.
Results
18F-FDG UPTAKE IN KNEE OA AND SUV
Figure 1 shows representative coronal and axial sections
of PET images in a knee with OA [Fig. 1(A)e(C)] and in
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Fig. 3. SUVs at the joint level were compared between the medial condyle and the lateral condyle (A,B). SUVs of the medial condyle were
higher than those of the lateral condyle (C). The data were expressed as the mean and standard deviation, and compared using a paired t-test.
*P< 0.05.a control knee [Fig. 1(D) and (E)]. 18F-FDG commonly accu-
mulated in the periarticular region and was lacking in the
articular cartilage. While the knee joint was demarcated
by various signal intensities in OA, there was little uptake
of 18F-FDG in the controls. Accumulation of 18F-FDG in
the intercondylar notch was a prominent feature in knee
OA [Fig. 1(C)]. A high uptake in the intercondylar lesion
was seen in 13 of 15 knees, and the mean SUV in the lesion
was 1.085 0.21, whereas that of the whole knee joint was
0.519 0.10.
The SUVs of whole knees were assessed using 3D
data [Fig. 2(A) and (B)]. Both mean and peak SUVs
were signiﬁcantly higher in OA than in controls [Fig. 2(C)
and (D)]. When the SUVs were compared between the
medial condyle and the lateral condyle at the joint level,
the former levels were signiﬁcantly higher than the latter
(Fig. 3).LOCALIZATION OF 18F-FDG ACCUMULATION IN INDIVIDUAL
CASES
Serial fusion images of MRI and PET were made to
specify the location of 18F-FDG accumulation. Twelve
knees had deﬁnite osteophytes and six of these (50%)
showed high accumulation of 18F-FDG around the osteo-
phytes (Fig. 4). High accumulation of 18F-FDG in the
intercondylar notch was observed in most cases, and
the accumulation extended along the posterior cruciate
ligament (PCL) in four knees (Fig. 5, Table I). 18F-FDG
accumulation was found in the subchondral region of
the medial tibial condyle in four cases. Enhanced uptake
was limited in the subchondral lesion of the base of the
osteophytes in three knees. The lesions gave a low
signal on proton density-weighted MRI and a high signal
on fat-suppressed MRI, suggesting bone edema (Fig. 6).
677Osteoarthritis and Cartilage Vol. 15, No. 6Fig. 4. 18F-FDG accumulation was found around medial osteophyte (Arrow). (A) Fusion image, (B) MRI, (C) PET axial view, and
(D) PET coronal view.In another case, extensive 18F-FDG uptake was found in
the bone marrow, spreading out into the medial soft tis-
sue that was speculated to be synovium or ligament
(Fig. 7).
PET FINDINGS AND CLINICAL MANIFESTATIONS
Maximum SUV and mean SUV were compared between
patients with and without clinical ﬁndings: effusion, swelling,
and rest pain; however, no signiﬁcant difference was
observed between them. Similarly, SUVs were compared
between radiological grading and no signiﬁcant relation
was found (Table II).
Discussion
PET images can delineate the distribution of inﬂamma-
tory tissue such as synovitis. Although OA has inﬂamma-
tory aspects19, PET has received little attention in OA till
date. As far as we know, there is only one report
evaluating shoulder OA by 18F-FDG PET20. In this report,
the 18F-FDG uptake pattern of shoulder OA was circum-
ferential and diffused, and they speculated that this
ﬁnding reﬂected the presence of mild synovitis. In ourseries, a periarticular pattern was a common ﬁnding in
knee OA, and the SUVs in OA were signiﬁcantly higher
than those in young, healthy controls. Thus, higher
SUVs in knee OA also suggested the presence of
synovitis.
Apart from peripheral uptake, high 18F-FDG accumulation
was found in the intercondylar notch with various intensities
in OA, and the accumulation extended along the PCL in
some cases. It has been reported that ligament damage
is more common in painful knee OA21. Thus, ligament
tear may be one of the causes of 18F-FDG accumulation
around the PCL, as well as periligamentous synovitis. In
addition, accumulation of 18F-FDG was found around osteo-
phytes. Osteophytes represent new bone formation associ-
ated with cartilaginous differentiation similar to fetal growth
plate cartilage22. In these regions, metabolism is upregu-
lated in terms of GAG production and new bone formation.
Enhanced 18F-FDG uptake around osteophytes reﬂects the
upregulated metabolism of osteochondral tissue in osteo-
phytes and/or soft tissue inﬂammation around osteophytes.
18F-FDG accumulation was found in bone marrow le-
sions. These lesions gave a low signal on proton den-
sity-weighted MRI and a high signal on fat-suppressed
MRI. Similar bone marrow changes in knee OA have
been reported as bone edema23, and these lesions
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and predicted focal deterioration. Histologically, these
lesions show abnormal bone with excessive ﬁbrosis, small
areas of osteonecrosis, and extensive bony remodeling24.
Thus, a change in OA is not restricted to the cartilage
and synovium, but also occurs in bone marrow. More-
over, bone edema might be inﬂuenced by circumferential
inﬂammation. As matrix production is enhanced in the
earlier stages of OA25, 18F-FDG uptake is expected to
be high. However, no enhanced uptake was found in
articular cartilage, even in the lower K/L grade knees.
The limitations of our study include the lack of an ade-
quate number of age-matched comparisons. As this was
a preliminary study of 18F-FDG PET in knee OA, contrastive
subjects were selected as controls. As far as we know, no
age-related changes in PET of joints have been elucidated.
To validate the diagnostic value of PET, early-stage OA
should be also assessed.
In summary, 18F-FDG uptake was upregulated in OA,
commonly accumulating in periarticular regions. Interest-
ingly, increased uptake was seen in the intercondylar
notch and accumulation was found along the PCL. 18F-
FDG uptake was also found in bone marrow lesions.
These results provide in vivo pathognomonic insights
into OA.Table I
Demographic features and 18F-FDG uptake
Case Age Sex K/L SUV Accumulation pattern
Maximum Mean peri
PCL
Subchondral
region
1 51 F R 1 0.70 0.36 þ
2 51 F R 3 1.06 0.42 þ þ
3 58 F R 3 0.96 0.45
4 68 F L 3 0.90 0.42 þ
5 68 F L 4 1.33 0.68
6 72 F L 3 1.12 0.58
7 73 F R 1 1.09 0.56
8 75 F L 3 1.08 0.58 þ þ
9 76 F L 1 1.57 0.64 þ
10 76 F R 2 0.93 0.47
11 78 F L 3 1.05 0.56
12 79 M L 2 1.39 0.70
13 80 F L 2 0.80 0.40
14 81 M R 3 0.90 0.44 þ
15 87 F R 4 1.10 0.54
R: Right, L: Left, þ: Present.
Fig. 6. 18F-FDG accumulated in the subchondral lesion of the base of the osteophytes. MRI study suggested the lesion as bone edema.
(A) Fusion image, (B) proton density-weighted MRI, (C) fat-suppressed MRI, (D) PET axial view, and (E) PET coronal view.
Fig. 7. 18F-FDG uptake was found in the bone marrow, spreading out into the medial soft tissue that was speculated to be synovium or
ligament. (A) Fusion image, (B) proton density-weighted MRI, (C) fat-suppressed MRI, (D) PET axial view, and (E) PET coronal view.
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18F-FDG uptake and clinical findings and radiological grading
Clinical ﬁndings Max SUV Mean SUV
Absent Present P Absent Present P
Effusion 1.03 0.17 1.11 0.26 NS 0.50 0.10 0.54 0.10 NS
Swelling 0.89 0.19 1.09 0.21 NS 0.47 0.11 0.53 0.10 NS
Rest pain 1.07 0.25 1.06 0.70 NS 0.50 0.11 0.54 0.09 NS
Radiological grading* I II III IV I II III IV
1.12 0.36 1.04 0.25 1.01 0.08 1.22 0.44 NS 0.52 0.12 0.52 0.13 0.49 0.07 0.61 0.21 NS
Values were the mean SD. Comparisons were made by Student’s t-test in clinical ﬁndings and one-way ANOVA in radiological
grading. NS¼ not signiﬁcant. * K/L grade.Acknowledgment
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